GB2218983A — Spiro-substituted glutaramides as diuretics
Assigned to Pfizer Ltd Great Britain · Expires 1989-11-29 · 36y expired
What this patent protects
Compounds of the formula: <IMAGE> wherein A completes a 4 to 7 membered carbocyclic ring which may be saturated or mono-unsaturated and which may optionally be fused to a further saturated or unsaturated 5 or 6 membered carbocyclic ring; x is a bridged cyclic group of th…
USPTO Abstract
Compounds of the formula: <IMAGE> wherein A completes a 4 to 7 membered carbocyclic ring which may be saturated or mono-unsaturated and which may optionally be fused to a further saturated or unsaturated 5 or 6 membered carbocyclic ring; x is a bridged cyclic group of the formula:- <IMAGE> wherein Y is O, CH2 or (CH2)2, or a bicyclic group of the formula:- <IMAGE> wherein each of n and m is independently 1 or 2 and q is an integer of from 3 to 5; each of R and R<4> is independently H, C1-C6 alkyl, benzyl or an alternative biolabile ester-forming group; R<1> is H or C1-C4 alkyl; R<2> and R<3> are each independently H, OH, C1-C4 alkyl or C1-C4 alkoxy; and R<5> is a substituent; and pharmaceutically acceptable salts thereof and bioprecursors therefor. The compounds are diuretic agents having utility in the treatment of cardiovascular disorders such as hypertension and heart failure.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.